Goodwin Procter advised North Island Ventures on the deal. North Island Ventures announced the closing of its NIV Fund II with $125 million in commitments. With this...
North Island Ventures’ Closing of NIV Fund II
Garuda Therapeutics’ Launch and $72 Million Series A Financing
Goodwin Procter advised Garuda Therapeutics on the deal. Garuda Therapeutics announced its launch and $72 million Series A financing led by Aisling Capital, Northpond Ventures, and OrbiMed,...